Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

23.02 -0.46 (-1.96%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
49 50 Next >
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities. 
Via MarketBeat
News headline image
1 Stock Under $50 on Our Watchlist and 2 to Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Is Hims & Hers Stock Too Cheap to Pass Up? ↗
This high-growth stock may be cheaper than you think. 
Via The Motley Fool
News headline image
Check Out What Whales Are Doing With HIMS ↗
 
Via Benzinga
News headline image
Should You Buy Hims & Hers Stock on the Dip? ↗
Via The Motley Fool
News headline image
Forecasting The Future: 15 Analyst Projections For Hims & Hers Health ↗
 
Via Benzinga
News headline image
Smart Money Is Betting Big In HIMS Options ↗
 
Via Benzinga
News headline image
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%? ↗
Via The Motley Fool
Topics Earnings
News headline image
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped ↗
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. 
Via The Motley Fool
News headline image
Hims & Hers Health's Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug Administration raised concerns about unapproved GLP-1 drugs used for weight... 
Via StockStory
Topics Supply Chain
News headline image
Why Hims & Hers Stock Just Collapsed ↗
Via The Motley Fool
News headline image
Market Whales and Their Recent Bets on HIMS Options ↗
 
Via Benzinga
News headline image
Why Hims & Hers Stock Tumbled on Tuesday ↗
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock. 
Via The Motley Fool
News headline image
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
News headline image
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug. 
Via MarketBeat
News headline image
Why Hims & Hers Stock Popped on Monday ↗
Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock? 
Via The Motley Fool
News headline image
2 High-Flying Stocks with Exciting Potential and 1 to Turn Down
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
From Defiance ETFs
Via GlobeNewswire
News headline image
Why Hims & Hers Health Stock Just Popped ↗
Via The Motley Fool
News headline image
4 Top Stocks to Buy Under $100 ↗
Here are four stocks to buy now that could offer investors upside in the short and long terms. 
Via The Motley Fool
News headline image
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity? ↗
Shutting down an acquisition caught investor attention, but there's more to the story. 
Via The Motley Fool
News headline image
The State of Weight Loss Drugs ↗
Via The Motley Fool
News headline image
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease. 
Via MarketBeat
News headline image
3 Cold Stocks That Can Bounce Back This Week ↗
These three stocks tumbled by at least 20% last week, but they may not be down for long. 
Via The Motley Fool
News headline image
MarketBeat Week in Review – 03/03 - 03/07
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue 
Via MarketBeat
Topics Economy
News headline image
This Could Be a Huge Blow to Hims & Hers Health Stock ↗
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It ↗
Via The Motley Fool
News headline image
Why Is Hims & Hers Health Stock Trading Lower On Wednesday? ↗
Hims & Hers Health stock drops over 20% after the FDA removes semaglutide from the shortage list. Novo Nordisk launches a direct delivery service for Wegovy. 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.